2026-01-04 - Analysis Report
Okay, let's break down the analysis of Air Products and Chemicals Inc. (APD) based on the data provided.

**0) Overview**

We will start by presenting the numerical data and then follow it with analysis.

**1) Return Rate Comparison (APD vs. S&P 500 (VOO))**

*   **APD:** Cumulative Return = -10.43%
*   **VOO (S&P 500):** Cumulative Return = 91.00%
*   **Divergence:** Current = -103.8, Relative Divergence = 3.6

**APD Company Overview:**  Air Products and Chemicals Inc. is an industrial gases company supplying atmospheric and process gases, and related equipment to various industries.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha   | Beta | Cap(B) |
|------------|--------|--------|---------|------|--------|
| 2016-2018  | 6.0%   | 12.1%  | 2.0%    | 0.9  | 35.6   |
| 2017-2019  | 34.0%  | 12.1%  | 17.0%   | 0.9  | 52.3   |
| 2018-2020  | 17.0%  | 20.5%  | -4.0%   | 1.0  | 60.8   |
| 2019-2021  | 41.0%  | 20.5%  | -3.0%   | 1.0  | 67.7   |
| 2020-2022  | 4.0%   | 28.5%  | 6.0%    | 0.9  | 68.6   |
| 2021-2023  | -26.0%  | 28.5%  | -27.0%  | 0.8  | 61.0   |
| 2022-2024  | -36.0%  | 31.2%  | -56.0%  | 0.7  | 64.6   |
| 2023-2025  | -61.0%  | 31.2%  | -123.0% | 0.7  | 55.0   |

**Analysis:**

*   **Underperformance:** APD has significantly underperformed the S&P 500, with a substantial negative divergence in cumulative return.
*   **Relative Divergence:** A relative divergence of 3.6 indicates that the current divergence is near the lowest end of its historical range. This *could* suggest a potential for recovery, but it's not a guarantee.
*   **Alpha & Beta:** The Alpha values have been predominantly negative, particularly in recent years, showing underperformance relative to its risk (Beta). Beta values are around 0.7 - 1.0 which indicates the stock's volatility is similar to that of the market.
*   **CAGR & MDD:**  The table highlights a decline in CAGR (Compound Annual Growth Rate) and a rise in MDD (Maximum Drawdown) over recent periods, reflecting increasing volatility and poor performance.

**2) Recent Stock Price Fluctuations**

*   **Current Price:** 250.47
*   **Previous Close:** 245.23
*   **Change:** 2.14
*   **5-day SMA:** 248.32
*   **20-day SMA:** 245.34
*   **60-day SMA:** 252.01

**Analysis:**

*   **Recent Uptick:** The stock price has seen a recent increase, closing higher than its previous close. The 5-day SMA is above the 20-day SMA, indicating a short-term upward trend.
*   **SMA Relationship:** The current price is below the 60-day SMA but above the 5 and 20 day SMAs. This suggests the stock is potentially facing resistance at the 60-day level but showing some short-term strength.

**3) RSI, PPO, and Expected Return**

*   **MRI:** 0.8 (Medium Investment Recommendation)
*   **RSI:** 61.17
*   **PPO:** 0.44
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (6 shares - Safe - MRI:0.80) Dividend_1.79 Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2026-01-02)
*   **Recent Divergence Change:** 1.6 (+) (Short-term Increase)
*   **Expected Return:** -849.2%

**Analysis:**

*   **MRI:** The Market Risk Indicator suggests a medium investment recommendation.
*   **RSI:** An RSI of 61.17 indicates that the stock is neither overbought nor oversold.
*   **PPO:** A positive PPO suggests bullish momentum, but the value of 0.44 is relatively low, so that the strength is very limited.
*   **Hybrid Signal:** The hybrid signal suggests that the algorithm favors a buy position, which is incongruent to the Expected Return value.
*   **Divergence Change:** The recent increase in relative divergence implies a short-term upward movement, aligning with the recent price uptick.
*   **Expected Return:** The extremely negative Expected Return suggests analysts/models predict continued underperformance compared to the S&P 500 *if* invested from now and held long-term. *This is a strong bearish indicator.*

**4) Recent News & Significant Events**

*   **Negative Press:** The news headlines are a mix, but several lean negative:
    *   A 25% drop in APD stock.
    *   Rep. Julie Johnson unloaded APD stock.
    *   A fraud investigation is possible.
*   **Positive Press:** A Bernstein analysis maintains an "Outperform" rating following hydrogen megaproject announcements, and one article mentions "de-risking moves" that could support a re-rating.
*   **Conflicting Narratives:** There's a clear conflict in the news, with negative factors (stock drops, potential fraud) contrasting with positive outlooks from some analysts regarding future projects.

**4-2) Analyst Opinions**

*   **Consensus:** Buy (Mean = 2.13)
*   **Target Price:** Average = $292.86, High = $340.00, Low = $245.00

**Analysis:**

*   **Conflicting Signals:** Analyst consensus is still generally positive (Buy rating with a target price higher than the current price), but this clashes with the negative momentum and negative expected return. This discrepancy warrants further investigation.
* **Recent Rating Changes:** The absence of recent rating change direction makes it difficult to measure analyst responsiveness to this negative trend.

**5) Recent Earnings Analysis**

| Date       | EPS    | Revenue  |
|------------|--------|----------|
| 2025-07-31 | 3.20   | 3.02 B$  |
| 2025-05-01 | -7.77  | 2.92 B$  |
| 2025-02-06 | 2.77   | 2.93 B$  |
| 2024-08-01 | 3.13   | 2.99 B$  |
| 2025-07-31 | 3.13   | 2.99 B$  |

**Analysis:**

*   **Volatility:** Earnings per share (EPS) show volatility, with a significant negative EPS in 2025-05-01. The last EPS data is not consistent, and there is an additional record that shouldn't be present.
*   **Revenue:** Revenue has been relatively stable, ranging between $2.92B and $3.02B.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
|------------|-----------|---------------|
| 2025-09-30 | $3.17B    | 32.25%        |
| 2025-06-30 | $3.02B    | 32.51%        |
| 2025-03-31 | $2.92B    | 29.57%        |
| 2024-12-31 | $2.93B    | 31.21%        |
| 2024-09-30 | $3.19B    | 33.98%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE     |
|------------|-----------|---------|
| 2025-09-30 | $15.02B   | 0.03%   |
| 2025-06-30 | $15.54B   | 4.59%   |
| 2025-03-31 | $14.70B   | -11.77%  |
| 2024-12-31 | $16.69B   | 3.70%   |
| 2024-09-30 | $17.04B   | 11.45%  |

**Analysis:**

*   **Revenue Trend:** Revenue shows some fluctuation.
*   **Profit Margin:** Profit margins appear relatively healthy, consistently above 30% except for one quarter.
*   **Equity:** Equity has generally decreased over the last few quarters.
*   **ROE:** Return on Equity (ROE) has been quite volatile and alarming in recent quarters, with a significant negative value. The recent quarter's ROE is near zero. This is a key area of concern.

**7) Comprehensive Analysis (Summary)**

APD is currently facing significant challenges.

*   **Underperformance:** It has substantially underperformed the S&P 500, with a negative cumulative return and a negative expected return.
*   **Negative Momentum:** Negative news headlines (stock drop, investigation), a recent increase in MDD, and a recent negative earnings quarter highlight near-term headwinds.
*   **Financial Strain:** Declining equity and volatile ROE (especially the recent very low and negative figures) raise concerns about the company's financial health.
*   **Analyst Disconnect:** While analyst consensus remains a "Buy", the negative technical indicators, recent news, and concerning financial data suggest a need for caution. This discrepancy indicates analysts may be slow to react to recent issues or have a longer-term outlook not reflected in short-term performance.
*   **Short-Term Hope:** There are some positives: A slight uptick in recent price, a positive PPO, and positive press from a few analysts indicate potential de-risking.

**Conclusion:**

Based on the provided data, APD presents a risky investment opportunity. While there are some potential positives, the negatives outweigh them. The underperformance compared to the market, negative expected return, recent negative news, and volatile financial metrics (especially ROE) suggest that investors should exercise caution. It would be prudent to do further research, closely monitor upcoming earnings reports and analyst revisions, and carefully consider your risk tolerance before investing in APD.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.